AGE1
Age1 is a venture capital firm that primarily invests in biotechnology companies. The firm is driven by a vision to make aging and age-related diseases optional for all.
AGE1
Industry:
Biotechnology Business Development
Founded:
2023-01-01
Status:
Active
Technology used in webpage:
Nginx U.S. Server Location AWS Global Accelerator Express Browse Happy
Similar Organizations
Genoa Ventures
Genoa Ventures is a venture capital firm that invests in early-stage life sciences technology companies.
Accomplice
Accomplice is a seed-led venture capital firm that primarily invests in technology startup companies.
Atom Bioscience & Pharmaceutical
Atom Bioscience is a clinical-stage biotechnology company.
Catalio Capital Management
Catalio Capital Management is a Venture capital investments in breakthrough biomedical technology companies.
Dimension Therapeutics
Dimension Therapeutics is a gene therapy company developing novel treatments for rare diseases.
G Squared
G Squared is a growth stage venture capital firm that invests privately in today's most dynamic companies.
Owl Ventures
Owl Ventures is a venture capital fund that invests in education technology companies.
Peroxitech Therapeutics
Peroxitech Therapeutics operates as a biopharmaceutical company.
Stabiliz Orthopaedics
Stabiliz Orthopaedics develops novel enhancements for orthopedic medical devices using FDA-approved technologies.
Current Advisors List
Advisor
2018-01-01
Current Employees Featured
Laura Deming Partner @ age1
Partner
2018-01-01
Omri Amirav-Drory Mentor @ age1
Mentor
2019-01-01
More informations about "age1"
age1 launches with $35 million to extend healthy lifespan
Sep 19, 2023 The founders feel that the launch of age1 comes at a critical point in time. Dr Alex Colville joins forces with Laura Deming. Loyal, a portfolio company from The Longevity Fund, made history in March 2023 when it was …See details»
Venture Capital Firm age1 Raises $35M to Advance Longevity …
Sep 25, 2023 age1, a venture capital firm specializing in longevity biotech, launched earlier this week in San Francisco announcing an initial closing fund of $35M.The firm aims to radically …See details»
‘We are so close to the future we want’
Oct 4, 2023 Last month, we covered the launch of age1, a San Francisco VC firm on a mission to lead investments in longevity science moonshots, catalyze the next generation of founder-led longevity biotech companies and advance …See details»
age1 - LinkedIn
Age1 | 1,316 followers on LinkedIn. Early backer of breakthrough, founder-led longevity companies | age1 funds breakthrough longevity companies addressing the core challenges of …See details»
age1 - Emerging Manager Monthly
Age1 is a biotech VC firm that funds healthy lifespan extension. Its predecessor fund is Longevity Fund, the first longevity-focused fund (5 IPOs w/ $1B raised in follow-on cap) founded by age1 …See details»
age1 - Crunchbase Investor Profile & Investments
Age1 is a venture capital firm that primarily invests in biotechnology companies. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. ... 2,384 Number of …See details»
Venture capital firm to fund next generation of …
Sep 25, 2023 A new venture capital firm, built on the foundation of The Longevity Fund, will help advance its mission funding the next generation of companies focused on extending healthy lifespan. Venture capital firm, Age1, …See details»
age1 Launches to Advance The Longevity Fund’s Mission to …
Sep 19, 2023 About age1 age1 is a venture capital firm that funds healthy lifespan extension. Built on the foundation of The Longevity Fund, age1 is extending its decade of expertise to …See details»
Venture firm age1 launches with $35 million to extend …
Sep 19, 2023 San Francisco-based age1, a venture capital firm catalyzing the next generation of founder-led longevity biotech companies, launched today to build a community. Agree & Join LinkedInSee details»
Venture firm age1 launches with $35 million to extend …
Sep 26, 2023 By Eleanor Garth - Logevity.Technology Dr Alex Colville joins forces with Laura Deming to advance The Longevity Fund’s mission and lead investments in longevity science moonshots. San Francisco-based age1, a …See details»
age1 Closes $35 Million To Invest In Longevity Biotech …
Sep 28, 2023 age1 - a VC firm catalyzing the next generation of founder-led longevity biotech companies - recently launched to build a community of visionaries advancing new therapeutics, tools, and technologies targeting …See details»
New Venture Firm Age1 Raises $35 Million Toward Early-Stage …
Sep 19, 2023 Laura Deming, 29, a well-known investor in the field who founded Longevity Fund in 2011, and Alex Colville, 30, who studied the biology of aging at Stanford University, have co …See details»
age1 Launches to Back Longevity Biotech Companies | citybiz
Sep 20, 2023 age1, a San Francisco, CA-based venture capital firm investing in the next generation of founder-led longevity biotech companies, officially launched.. The firm, which …See details»
Venture firm age1 launches with $35 million to extend healthy …
Sep 21, 2023 Venture firm age1 launches with $35 million to extend healthy lifespan Dr Alex Colville joins forces with Laura Deming to advance The Longevity Fund’s mission and lead …See details»
age1 Launches to Back Longevity Biotech Companies - FinSMEs
Sep 19, 2023 age1’s team has an industry-leading track record and unwavering commitment to the field, having pioneered the first longevity-focused venture capital fund in 2011 and since …See details»
AGE1 Company Profile: , Investments, Contact Information, News ...
AGE1 is an accelerator for longevity companies. Longevity is at an inflection point: due to scientific advances over the last 30 years, we are beginning to change how we interact with …See details»
age1 - liveforever.club
Oct 10, 2023 age1 is a venture capital firm that supports founder-led companies working on extending healthy human lifespan and addressing age-related diseases. They focus on …See details»
age1's vision - Libraries for the Future
Sep 19, 2023 age1 will seed the best founders the field has ever seen, equipping them with the right resources to finally attain proven safe, equitable interventions to delay, restore, replace, …See details»
age1 | Institution Profile - Private Equity International
Age1. News, insights, analysis and data. age1 overview. Founded in 2023, age1 is based in San Francisco and specialises in venture capital on biotechnology and therapeutics companies …See details»
Invocation of the Alien Enemies Act Regarding the Invasion of The ...
Mar 15, 2025 Based upon a review of TdA’s activities, and in consultation with the Attorney General and the Secretary of the Treasury, on February 20, 2025, acting pursuant to the …See details»